Literature DB >> 3979001

Effects of influenza virus vaccine on hepatic drug metabolism.

C G Meredith, C D Christian, R F Johnson, R Troxell, G L Davis, S Schenker.   

Abstract

Experimental and more limited clinical studies have suggested that influenza vaccination may depress the oxidative hepatic metabolism of various drugs and lead to drug toxicity. The alleged mechanism is the formation of interferon and the resulting decrease in cytochrome P-450 available for drug oxidation. Because of the clinical and basic science implications of these reports, we undertook to study the effects of influenza vaccine on the metabolism of three commonly used drugs: chlordiazepoxide, theophylline, and lorazepam. Our healthy male subjects were studied just before and 1 and 7 days after vaccination. As expected, lorazepam metabolism, which proceeds by glucuronidation and not oxidation, was not altered by vaccination. Surprisingly, however, the oxidation of chlordiazepoxide was also not depressed by the vaccine. Theophylline oxidation, which proceeds primarily by microsomal oxidation (demethylation), was significantly decreased 1 day, but not 7 days, after vaccination. Serum alpha-interferon levels rose after vaccination for only about 8 hours, and levels of gamma-interferon rose to about 500 IU/ml at 24 hours, peaked at 72 hours, and returned to normal by 100 hours after dosing. It appeared that the higher the theophylline clearance before vaccination, the greater the degree of clearance depression after vaccination. Thus the inhibition of drug oxidation after influenza vaccination is selective and each drug should be studied individually. The degree of depression of theophylline clearance is small and transient and appears to be greater in subjects with higher prevaccination clearance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3979001     DOI: 10.1038/clpt.1985.61

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

Review 1.  Vaccine-Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms.

Authors:  Paolo Pellegrino; Cristiana Perrotta; Emilio Clementi; Sonia Radice
Journal:  Drug Saf       Date:  2015-09       Impact factor: 5.606

Review 2.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

3.  On the possible interaction between vaccines and drugs.

Authors:  Paolo Pellegrino; Carla Carnovale; Valentina Perrone; Dionigi Salvati; Marta Gentili; Tatiana Brusadelli; Marco Pozzi; Stefania Antoniazzi; Emilio Clementi; Sonia Radice
Journal:  Eur J Clin Pharmacol       Date:  2013-12-05       Impact factor: 2.953

Review 4.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

5.  Lack of effect of influenza vaccine on warfarin anticoagulation in the elderly.

Authors:  I H Gomolin
Journal:  CMAJ       Date:  1986-07-01       Impact factor: 8.262

6.  The effect of pneumococcal vaccine on the disposition of theophylline.

Authors:  G C Cupit; T H Self; W B Bekemeyer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Bupivacaine kinetics during hyperthermia in rats.

Authors:  B Bruguerolle; X Roucoules; L Attolini; A M Lorec
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

8.  Inhibition of antipyrine metabolism by interferon.

Authors:  S J Williams; G C Farrell
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

9.  Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol.

Authors:  P A Soons; C Grib; D D Breimer; W Kirch
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

10.  Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepam.

Authors:  J M Scavone; G T Blyden; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.